US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ENvue Medical, Inc

3.84

+1.5466.96%

Post-market: 3.56-0.2800-7.29%19:59 EST

Volume:154.65M

Turnover:609.93M

Market Cap:4.18M

PE:-0.15

High:4.83

Open:2.24

Low:2.20

Close:2.30

52wk High:162.50

52wk Low:0.9900

Shares:1.09M

Float Shares:1.09M

Volume Ratio:2.82

T/O Rate:14213.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-25.9327

EPS(LYR):-137.2985

ROE:-30.51%

ROA:-19.99%

PB:0.10

PE(LYR):-0.03

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ENvue Medical, Inc

Exchange:

NASDAQ

Establishment Date:

2003

Employees:

31

Office Location:

969 Pruitt Ave,Tyler,Texas,United States

Website:

http://www.nanovibronix.com

Zip Code:

77569

Phone:

Fax:

- -

Introduction:

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas.

Directors

Name

Position

David Johnson

Chairman and Director

Doron Besser

Chief Executive Officer and Director

Alison Geiger Burgett

Director

Nino Pionati

Director

Zeev Rotstein

Director

Shareholders

Name

Position

Doron Besser

Chief Executive Officer and Director

Nicole Fernandez McGovern

Interim Chief Financial Officer

Harold Jacob

Chief Medical Officer

Rita Silberberg

Executive Vice President of Finance and Chief Accounting Officer, Corporate Secretary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FEED/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FEED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FEED\",,,,,undefined,":{"symbol":"FEED","market":"US","secType":"STK","nameCN":"ENvue Medical, Inc","latestPrice":3.84,"timestamp":1769720400000,"preClose":2.3,"halted":0,"volume":154651758,"hourTrading":{"tag":"盘后","latestPrice":3.56,"preClose":3.84,"latestTime":"19:59 EST","volume":1795986,"amount":6474541.0231,"timestamp":1769734798934,"change":-0.28,"changeRate":-0.072917,"amplitude":0.216146},"delay":0,"changeRate":0.6695652173913044,"floatShares":1088100,"shares":1088176,"eps":-25.932653,"marketStatus":"Not Yet Opened","change":1.54,"latestTime":"01-29 16:00:00 EST","open":2.24,"high":4.83,"low":2.2,"amount":609928841.3908849,"amplitude":1.143478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-25.932653,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1769763600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":2.3,"preHourTrading":{"tag":"盘前","latestPrice":2.21,"preClose":2.3,"latestTime":"09:29 EST","volume":563273,"amount":1190645.0028902001,"timestamp":1769696995651,"change":-0.09,"changeRate":-0.03913,"amplitude":0.130435},"postHourTrading":{"tag":"盘后","latestPrice":3.56,"preClose":3.84,"latestTime":"19:59 EST","volume":1795986,"amount":6474541.0231,"timestamp":1769734798934,"change":-0.28,"changeRate":-0.072917,"amplitude":0.216146},"volumeRatio":2.815013},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FEED\",,,,,undefined,":{"symbol":"FEED","floatShares":1088100,"roa":"-19.99%","roe":"-30.51%","lyrEps":-137.298499,"volumeRatio":2.815013,"shares":1088176,"dividePrice":0,"high":4.83,"amplitude":1.143478,"preClose":2.3,"low":2.2,"week52Low":0.99,"pbRate":"0.10","psRate":"1.56","week52High":162.5,"institutionHeld":0,"latestPrice":3.84,"eps":-25.932653,"divideRate":0,"volume":154651758,"delay":0,"ttmEps":-25.932653,"open":2.24,"prevYearClose":2.31,"prevWeekClose":1.1,"prevMonthClose":2.31,"prevQuarterClose":2.31,"fiveDayClose":1.16,"twentyDayClose":2.18,"sixtyDayClose":5.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FEED\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FEED\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FEED\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FEED\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FEED","date":"2026-01-28","current":-0.148076,"percent":1,"low":-0.659598,"twenty":-0.486823,"median":-0.372437,"eighty":-0.209144,"high":-0.168924,"avg":-0.372117,"sd":0.136027,"marketCap":1142601},"quantilePoints":[{"date":"2025-12-19","current":-0.537331,"twenty":-0.629996,"median":-0.571115,"eighty":-0.544088,"marketCap":3634507},{"date":"2025-12-26","current":-0.447246,"twenty":-0.591707,"median":-0.537331,"eighty":-0.468482,"marketCap":3025173},{"date":"2026-01-02","current":-0.371633,"twenty":-0.56098,"median":-0.48264,"eighty":-0.391389,"marketCap":2513723},{"date":"2026-01-09","current":-0.4022,"twenty":-0.542399,"median":-0.42955,"eighty":-0.374078,"marketCap":2720480},{"date":"2026-01-16","current":-0.234885,"twenty":-0.52382,"median":-0.394156,"eighty":-0.36391,"marketCap":1588760},{"date":"2026-01-23","current":-0.186621,"twenty":-0.499371,"median":-0.377746,"eighty":-0.28894,"marketCap":1262302},{"date":"2026-01-28","current":-0.168924,"twenty":-0.486823,"median":-0.372437,"eighty":-0.209144,"marketCap":1142601}],"updateTime":1769745079080},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":27619235,"yearFounded":2003,"employeeNum":31,"address":"969 Pruitt Ave,Tyler,Texas,United States","zipCode":"77569","officePhone":"914 233 3004"},"stockCompanyDetail":{"websiteUrl":"http://www.nanovibronix.com","stockEarnings":[{"period":"1week","weight":0.8254},{"period":"1month","weight":-0.0204},{"period":"3month","weight":-0.5669},{"period":"6month","weight":-0.7212},{"period":"1year","weight":-0.9465},{"period":"ytd","weight":-0.0043}],"compareEarnings":[{"period":"1week","weight":0.0146},{"period":"1month","weight":0.011},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1185},{"period":"1year","weight":0.1504},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.014153},{"month":2,"riseRate":0.5,"avgChangeRate":-0.068057},{"month":3,"riseRate":0.25,"avgChangeRate":-0.013493},{"month":4,"riseRate":0.25,"avgChangeRate":-0.111384},{"month":5,"riseRate":0.625,"avgChangeRate":-0.043561},{"month":6,"riseRate":0.25,"avgChangeRate":-0.091299},{"month":7,"riseRate":0.5,"avgChangeRate":0.194105},{"month":8,"riseRate":0.25,"avgChangeRate":-0.202514},{"month":9,"riseRate":0.5,"avgChangeRate":-0.056877},{"month":10,"riseRate":0.125,"avgChangeRate":-0.177989},{"month":11,"riseRate":0.625,"avgChangeRate":0.056057},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.100812}],"exchange":"NASDAQ","name":"ENvue Medical, Inc","nameEN":"ENvue Medical, Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FEED\",market:\"US\",,,undefined,":{"directors":[{"name":"David Johnson","position":"Chairman and Director"},{"name":"Doron Besser","position":"Chief Executive Officer and Director"},{"name":"Alison Geiger Burgett","position":"Director"},{"name":"Nino Pionati","position":"Director"},{"name":"Zeev Rotstein","position":"Director"}],"executives":[{"name":"Doron Besser","position":"Chief Executive Officer and Director"},{"name":"Nicole Fernandez McGovern","position":"Interim Chief Financial Officer"},{"name":"Harold Jacob","position":"Chief Medical Officer"},{"name":"Rita Silberberg","position":"Executive Vice President of Finance and Chief Accounting Officer, Corporate Secretary"}]}}}